LAMPRENE

This brand name is authorized in Estonia, France, Malta, South Africa

Active ingredients

The drug LAMPRENE contains one active pharmaceutical ingredient (API):

1 Chlofazimine UNII D959AE5USF - CLOFAZIMINE

Clofazimine is an antimycobacterial drug. Clofazimine exerts a slow bactericidal effect on Mycobacterium leprae (Hansen’s bacillus). Clofazimine inhibits mycobacterial growth and binds preferentially to mycobacterial DNA. Read about Chlofazimine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LAMPRENE Soft gelatin capsule	Health Products Regulatory Authority (ZA)	MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J04BA01	Clofazimine	J Antiinfectives for systemic use → J04 Antimycobacterials → J04B Drugs for treatment of lepra → J04BA Drugs for treatment of lepra
Discover more medicines within J04BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1738357
Country: FR	Base de données publique des médicaments	Identifier(s): 62768220, 67132888
Country: MT	Medicines Authority	Identifier(s): AA565/45101
Country: ZA	Health Products Regulatory Authority	Identifier(s): 53/20.2.4/0472, B/20.2.4/108